GeoVax Labs, Inc.
USD2.03
-0.07 (-3.33%)
CEO
David Alan Dodd
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.01
Prev. Close
$2.10
Day Low
$1.90
Day High
$2.08
52W Low
$0.96
52W High
$34.75
Market Cap
$0.00B
Volume
0.62M
| 10,000 |
| $2.48 |
| 6 Jun 2025 | CHASE RANDAL D | director | A-Award | Acquired | 10,000 | $2.48 |
| 6 Jun 2025 | Kollintzas Dean G | director | A-Award | Acquired | 10,000 | $2.48 |
| 6 Jun 2025 | MCNALLY ROBERT T | director | A-Award | Acquired | 10,000 | $2.48 |
| 6 Jun 2025 | Morgan Jayne | director | A-Award | Acquired | 10,000 | $2.48 |
| 6 Jun 2025 | SPENCER JOHN N JR | director | A-Award | Acquired | 10,000 | $2.48 |
| 6 Jun 2025 | NEWMAN MARK J | Chief Scientific Officer | A-Award | Acquired | 70,000 | $2.48 |
| 6 Jun 2025 | McKee Kelly T. Jr. | Chief Medical Officer | A-Award | Acquired | 70,000 | $2.48 |
| 6 Jun 2025 | Sharkey John W. | VP, Business Development | A-Award | Acquired | 70,000 | $2.48 |